Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Aug 6, 2019, after the close
10-Q filed Aug 6, 2019, 37 days after period end · 0001299130-19-000046
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $24.62M | $21.58M | $20.07M | $20.75M |
| Net Income | -$24.60M | -$22.54M | -$25.54M | -$18.50M |
| EPS Diluted |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.16 |
| -$0.17 |
| -$0.26 |
| -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
